Louisiana 2020 Regular Session

Louisiana House Bill HB385

Introduced
2/27/20  
Introduced
2/27/20  
Refer
2/27/20  
Refer
2/27/20  
Refer
3/9/20  

Caption

Repeals the prohibition on medical marijuana in raw or crude form

Impact

If enacted, HB 385 is expected to have a profound impact on state laws regulating medical marijuana. By lifting restrictions on inhalation and raw forms of marijuana, the bill aligns Louisiana's medical marijuana framework with the broader trends observed in other states, which have begun to embrace more liberal approaches to cannabis for medicinal purposes. This legislative adjustment could enhance the quality of life for many patients who may benefit from alternative consumption methods that are less processed and potentially more effective in addressing their symptoms.

Summary

House Bill 385 proposes a significant change to Louisiana's medical marijuana laws by removing the prohibitions against prescribing raw or crude marijuana and the method of inhalation for therapeutic use. The bill allows physicians, who are licensed by the Louisiana State Board of Medical Examiners, to recommend medical marijuana in forms other than those previously sanctioned, thereby expanding the options available to patients diagnosed with debilitating medical conditions. This legislative change represents a step toward greater accessibility and flexibility in the therapeutic application of marijuana, acknowledging the evolving perceptions and medical understandings surrounding its use.

Sentiment

The sentiment surrounding HB 385 appears to be generally positive among its supporters, who view it as a necessary reform that acknowledges and responds to patients' needs. Advocates for the bill argue that the current restrictions limit the effectiveness of treatment options available to those suffering from chronic conditions. However, there are likely to be opponents who express concerns regarding the implications of wider availability of raw cannabis, fearing potential abuse or misuse, and the need for appropriate regulatory measures to ensure safe and responsible use.

Contention

Notable points of contention might arise over the methods of administration and the safety standards that accompany the use of raw or inhaled marijuana. Advocates emphasize the importance of patient autonomy and access to varied treatment options, while opponents may raise issues regarding public health and safety, suggesting that the absence of comprehensive regulation on new forms of delivery could lead to complications. The discussions around this bill may also touch on the efficacy of raw versus processed cannabis products and the medical community's stance on what constitutes safe and effective treatment.

Companion Bills

No companion bills found.

Similar Bills

HI SB704

Relating To Marijuana.

AZ HB2082

Marijuana; sampling; advertising; sale

AZ HB2770

Marijuana; interstate agreements; delivery

CT HB05458

An Act Concerning The Regulation Of The Retail Sale Of Marijuana.

AZ SB1410

Marijuana; licensing; delivery

HI HB7

Relating To Marijuana.

VA SB1233

Marijuana; advertising restrictions, penalties.

VA HB2428

Marijuana; advertising restrictions, penalties.